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Abstract
Pax3 is expressed early during embryonic development in spatially restricted domains including limb muscle, neural crest, and neural tube. Pax3
functions at the nodal point in melanocyte stem cell differentiation, cardiogenesis and neurogenesis. Additionally Pax3 has been implicated in
migration and differentiation of precursor cell populations. Currently there are questions about how Pax3 regulates these diverse functions. In this
study we found that in the absence of functional Pax3, as in Splotch embryos, the neural crest cells undergo premature neurogenesis, as evidenced
by increased Brn3a positive staining in neural tube explants, in comparison with wild-type. Premature neurogenesis in the absence of functional
Pax3 may be due to a change in the regulation of basic helix–loop–helix transcription factors implicated in proliferation and differentiation. Using
promoter-luciferase activity measurements in transient co-transfection experiments and electro-mobility shift assays, we show that Pax3 regulates
Hairy and enhancer of split homolog-1 (Hes1) and Neurogenin2 (Ngn2) by directly binding to their promoters. Chromatin immunoprecipitation
assays confirmed that Pax3 bound to cis-regulatory elements within Hes1 and Ngn2 promoters. These observations suggest that Pax3 regulates
Hes1 and Ngn2 and imply that it may couple migration with neural stem cell maintenance and neurogenesis.
© 2008 Elsevier Inc. All rights reserved.Keywords: Pax3; Neurogenin2; Hes1; Chromatin immunoprecipitation; Premature neurogenesis; Stem cells; Neural tube; Splotch; Promoter; Explant culturesIntroduction
The basic helix–loop–helix (bHLH) family of transcrip-
tional regulatory proteins are key players in a wide array of
developmental processes. Proneural genes encode bHLH trans-
cription factors that are essential for early steps in neurogenesis,
in both Drosophila (Campuzano and Modolell, 1992) and
vertebrates (Guillemot, 1999; Kageyama et al., 2005). Neuro-
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doi:10.1016/j.ydbio.2008.01.008progenitors to leave the cell cycle and activate the neuronal
differentiation program (Theriault et al., 2005). The bHLH
gene, Hairy and enhancer of split homolog-1 (Hes1) and other
Hes genes regulate maintenance of neural stem cells and pro-
mote gliogenesis (Theriault et al., 2005; Shen et al., 2004). Barsi
et al. (2005) showed that aberrant neurogenesis is a direct con-
sequence of lowered Hes1 and Hes5 expression. Ishibashi et al.
(1995) found that mice lacking the HLH repressor, Hes1,
display a marked neural tube defect that may be the result of
premature neurogenesis. Hirata et al. (2001) reported that Hes1
and Hes3 double knockout prevents early neurogenesis. Over-
all, inactivation of Hes1 accelerates early neurogenesis and
decreases the number of late born neurons because of neuronal
precursor depletion (Ishibashi et al., 1994; Tomita et al., 1996;
Ohtsuka et al., 1999; Cau et al., 2000; Nakamura et al., 2000).
Another proneural bHLH transcription factor, Neurogenin 2
(Ngn2), plays a critical role in the acquisition of pan-neuronal
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2001), the specification of neuronal subtypes (Ma et al., 1999;
Fode et al., 1998, 2000; Mizuguchi et al., 2001; Parras et al.,
2002; Schuurmans et al., 2004; Seibt et al., 2003; Ross et al.,
2003) and sensory neurogenesis (Lo et al., 2002). Ngn2 is
involved in the neurogenesis of neural crest cells (Theriault
et al., 2005). This transcription factor is expressed early in
neural crest migration, as well as in a subset of cells at the dorso-
lateral margins of the neural tube, in both mouse (Ma et al.,
1999) and chick (Perez et al., 1999). Gain-of-function studies
with Ngns suggest that by the time neural crest cells express
these proneural genes they may be determined as well as spe-
cified for a sensory fate as evidenced by the expression of the
sensory-specific marker Brn-3.0 (Lo et al., 2002; Anderson,
2000). Nieto et al. (2001) examined the role of the proneural
bHLH genes Ngn2 and Mash1 in the selection of neuronal and
glial fates by neural stem cells. An analysis of wild-type and
mutant cortical progenitors in culture showed that a large frac-
tion of Ngn2:Mash1 double-mutant progenitors failed to adopt
a neuronal fate, instead remaining pluripotent or entering an
astrocytic differentiation pathway.
On the whole, Hes1 and Ngn2 are key bHLH transcription
factors responsible for proper maintenance of neural stem cells
and sensory neuronal differentiation, respectively. Currently,
little is known about the transcriptional regulation of these
bHLH factors. In this study we investigated the question: does
the paired-box gene transcription factor, Pax3, play a role in
regulating Hes1 and Ngn2. To help determine the answer we
used Splotch (Sp/Sp) embryos, which lack functional Pax3.
‘Splotch’ (Sp/Sp) is an established mouse model for neural tube
defects (NTD), associated with spina bifida and exencephaly.
Epstein et al. (1991) mapped the paired box gene Pax3 to a
region at the Sp locus on mouse chromosome 1 and found Pax3
to be deleted in mice heterozygous for a splotch allele. Further
studies on the integrity of the Pax3 gene and its cellular mRNA
transcript in the spontaneously arising Sp allele showed a
complex mutation in the Pax3 gene in the Sp/Sp mutant. This
genomic mutation resulted in the generation of four aberrantly
spliced mRNA transcripts. These transcripts did not result in
functional Pax3 proteins and were responsible for the phe-
notype observed in the Sp/Sp mouse mutant (Epstein et al.,
1993).
On examining neurogenesis in Splotch embryos we found
that they exhibit premature neurogenesis as evidenced by an
increase in Brn3a positive neural crest cells. This increase may
be due to Pax3 regulating bHLH transcription factors. Since
Hes1 prevents premature neurogenesis (Hirata et al., 2001) and
Ngn2 plays a critical role in sensory neurogenesis (Lo et al.,
2002), these two were likely candidates for Pax3 regulation.
Our initial results showed that Hes1 and Ngn2 expression were
significantly decreased in Splotch embryos as compared to wild
type. This supported a role for Pax3 in regulating these trans-
cription factors. We then determined that Pax3 appears to di-
rectly bind to the cis-regulatory elements on the Hes1 and Ngn2
promoters. In summary, the studies reported here support the
hypothesis that Pax3 plays an important role in regulating Hes1
and Ngn2 during mouse embryonic development.Materials and methods
Antibodies and reagents
We obtained p21 monoclonal antibody (sc-6246) and NeuroD goat poly-
clonal antibody (sc-1084) from Santa Cruz Biotechnologies; anti-Pax3 rabbit
polyclonal antibody (CA1010) from EMD Biosciences and anti-Brn3a
(Ab5945) rabbit polyclonal antibody from Chemicon; anti-Pax3 mouse
monoclonal antibody from Developmental Studies Hybridoma Bank. Donkey
anti-rabbit IgG-Cy3 and donkey anti-goat IgG-Cy2 were from Jackson
Immunochemicals. IgG from rabbit serum (I-5006), EGF (E9644) and DAPI
were from Sigma, bFGF (233-FB) from R&D Systems. Growth factor reduced
Matrigel (35-6230) from BD Biosciences. Papain L-cysteine and EDTA
(LK003176) from Worthington and Neurobasal Plus from Invitrogen.
Genotyping
The C57BL/6J-Pax3Sp/J (stock=2469) male and C57BL/6J breeding pairs
were obtained from The Jackson Laboratory. Genotyping of Pax3+/+ (wild-
type), Pax3+/− heterozygous (Sp/+), and Pax3−/− homozygous (Sp/Sp) embryos
was performed on isolated genomic DNA from embryonic membranes using
PCR with a Pax3+/+ (wild-type) or Sp/Sp homozygous specific reverse primer
and a common forward primer in separate PCRs as described by Epstein et al.
(1996).
Neural tube explant cultures and neural crest migration
Embryos for neural tube explant culture and neural crest migration studies
were obtained by mating Sp+/− heterozygous male and female mice. The day
the vaginal plug was found was considered E0.5. Embryos were collected at
E10.0 and E12.5, and the head or yolk sac was harvested for genotyping by
PCR. Neural tube explant cultures from the lower lumbar region of E10.0 and
E12.5 wild type and Sp/Sp embryos were grown in Neurobasal medium
supplemented with bFGF (20 ng/ml) and EGF (20 ng/ml) on Matrigel coated 24
well plates. Neural crest cells were allowed to migrate for 140 h. The migration
index of neural crest was calculated as the total area of the outgrowth minus the
area of the dense central neural tube mass (Epstein et al., 2000). Explant cultures
were then grown in Neurobasal medium without bFGF and EGF and allowed to
differentiate for 2 additional days. Following differentiation, explants were fixed
in 4% formalin for 30 min at 4 °C and stained for Brn3a (sensory neurogenesis
marker), NeuroD (marker for early neuronal differentiation) and DAPI (nuclear
stain). In separate experiments, differentiated neural crest cells were stained for
p75NTR (neural crest stem cell marker) and Pax3 to verify that all neural crest
cells expressing marker co-express Pax3 (data not shown).
Real time quantitative RT-PCR
Real time quantitative RT-PCR was done as described in our previous papers
(Mayanil et al., 2000, 2001). Primers and probes used in this study were
designed using Primer Express software (PerkinElmer Life Sciences). Primers
were synthesized by Operon Inc. and probes were synthesized by MegaBases
Inc. For murine Hes1 (Accession # NM_008235) we used: forward primer: 5′-
ggtcctaacgcagtgtcacctt-3′; reverse primer: 5′-cagtggcctgaggctctca-3′; TaqMan
Probe: FAM-ctcctcgctcacttcggactccatgt-TAMRA. For murine Ngn2 (Accession
# AF303001) we used: forward primer: 5′-agaggtggcccttgcaatc-3′; reverse
primer: 5′-cacacgccatagtcctctttga-3′; TaqMan Probe: FAM-ctcggcggctggtgcatt-
TAMRA. For murine β-actin we used: forward primer 5′-acggccaggtcatcacta
ttg-3′, reverse primer 5′-tggatgccacaggattcc a-3′ and TaqMan Probe FAM-caac-
gagcggttccgatgccc-TAMRA.
Whole mount in situ hybridization
Whole mount in situ hybridization was done as described in Wilkinson
(1992). Washes were performed at 65 °C. The antisense digoxigenin labeled
mouse Hes1 riboprobe was created by linearizing with EcoR1 and synthesized
using T7 polymerase. The sense riboprobe was made by linearizing with BamH1
and synthesized using T3 polymerase. The antisense digoxigenin labeled mouse
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polymerase. The sense probe was made by linearizing with EcoR1 and
synthesized using SP6 polymerase. Embryos were stained and photographed
with a Spot Camera (Diagnostic Instruments Inc.).
Chromatin Immunoprecipitation (ChIP) assays
ChIP assays using lumbar neural tube from wild-type (Pax3+/+) and open
neural tube from Sp/Sp embryos (E10.0) were performed as described earlier
(Mayanil et al., 2006). PCR was performed with primers for the murine Hes1
and Ngn2 promoter region. All ChIP samples were tested for false-positive
PCR amplification by sequencing the 200-bp amplified product to ascertain
the specificity of Pax3 binding to cis-regulatory elements. Additionally, false
positive PCR amplification was ruled out by amplifying the sequence from
the murine β-actin promoter: forward 5′-gtgggccgccctaggcaccag-3′ and
reverse 5′-ctctttgatgtcacgcacgatttc-3′. This sequence failed to give any PCR
product in the immunoprecipitates. Primers for PCR amplification were as
follows: for murine Hes1 promoter: forward (bp98–118) 5′-ttggctgaaagt-
tactgtgg-3′ and reverse (bp279–299) 5′-tcttagggctacttagtgat-3′ and for murine
Ngn2 promoter: forward (bp6881–6900) 5′-ggcagatctgattgttttct-3′ and reverse
(bp7061–7080) 5′gcagctcgcccgagtctcgt-3′ which amplified a 200-bp fragment
in each case.
Electro-mobility shift assays (EMSA)
Probes were prepared for EMSA by annealing complementary oligonucleo-
tides representing selected regions of murine Hes1 and Ngn2 promoters,
followed by 5′-end labeling with [γ-32P] ATP by T4 polynucleotide kinase.
EMSAwas done as described (Mayanil et al., 2001, 2006). Double-stranded 30-
mer oligonucleotide probes were made which covered the following regions:
Hes1 promoter Hes1oligo#1: 5′-cattggccgccagaccttgtgcctagcggc-3′ and He-
s1oligo#2: 5′-tgtctacctctctccttggtcctggaa tag-3′; Ngn2 promoter Ngn2oligo: 5′-
gacaccgtgctcggttccgggctgcgggga-3′. For supershift assays 0.1 μg polyclonal
Pax3 antibody was preincubated on ice for 30 min with nuclear extract or
GST–Pax3 fusion protein prior to addition of labeled oligonucleotides. After
20-min incubation, free DNA and DNA protein complexes were resolved in 4%
(in case of nuclear extracts) and 8% (in case of GST-Pax3 fusion protein),
polyacrylamide gels using 0.25× TBE as the running buffer. Electrophoresis
was performed at 4 °C at 300 mV and 30 mA for 3 h. Gels were dried and
subjected to PhosphorImager (Amersham Biosciences) analysis to view shifted
bands.
Analysis of Hes1 and Ngn2 promoter activity
Hes1 promoter construct Hes1 (−467 to +46)-luciferase was provided by
Dr. R. Kageyama (Takebayashi et al., 1994). Two deletion mutants within the
Hes1-promoter (−467 to +46) luciferase reporter constructs (Fig. 3) were
made with the QuickChangeXL site-directed mutagenesis kit (Stratagene): The
“cc” within the Pax3 binding sites (bp34–38) ccttg and (bp254–258) ccttg were
mutated in Hes1 mutant 1 and Hes1 mutant 2 respectively (Fig. 2). Hes1
promoter-luciferase) (−467 to +46) containing plasmid or plasmids containing
the mutated sequences (0.2 μg) were transiently co-transfected with Pax3-
pcDNA3 or pcDNA3 vector control into wild-type DAOY cells and luciferase
assays were done as described (Mayanil et al., 2006).
Five deletion mutants of the Ngn2-promoter (1.2 kb fragment; bp5498–
7254) (AF303001) luciferase reporter construct (Fig. 4) were made with the
QuickChangeXL site-directed mutagenesis kit (Stratagene): Ngn2-promoter
mutant#1 (bp5498–5880 deleted); mutant#2 (bp5498–6334 deleted); mutant#3
(bp6484–6745) mutant #4 (bp6470–7254 deleted); mutant#5 (bp5498–6754
deleted); mut5Δgttcc ‘gttcc’ (bps7184–7188) deleted from Ngn2 mutant#5
(bp6755–7254). Ngn2-promoter luciferase or its mutant constructs (0.2 μg)
were transiently co-transfected with Pax3-pcDNA3 or pcDNA3 vector control
into wild-type DAOY cells and luciferase assays were done as described
(Mayanil et al., 2006) using the Dual Luciferase kit from Promega. Renilla
luciferase plasmid, pRL-null (5 ng/well) (Dual Luciferase System Promega),
was simultaneously transfected as an insertional control for transfection
efficiency.Generation of neurospheres from E10.0 embryonic lower lumbar
tissue
Primary neurospheres from the lower lumbar regions of E10.0 embryos were
prepared by triturating the tissue with pre-warmed (37 °C) papain L-cysteine,
EDTA (Worthington, LK003176) at a final concentration of 20 μl per 5 ml. After
incubation at 37 °C for 30 min, 2.5 ml Neurobasal Plus (Invitrogen) was added
and the cells were centrifuged at 200×g for 5 min. The cells were washed with
2.5 ml×3 Neurobasal Plus and resuspended in 4 ml Neurobasal supplemented
with bFGF and EGF at a final concentration of 20 ng/ml. They were then
allowed to form neurospheres in flasks pre-coated with poly-heme for 10 days.
Immunoblotting and immunostaining
For immunoblotting the primary antibodies were anti-p21 mouse mono-
clonal antibody (1:1000); and anti-β-tubulin mouse monoclonal antibody
(1:3000). The secondary antibody was anti-mouse HRP conjugated antibody.
Antibody binding was revealed by enhanced chemiluminescence (ECL)
detection (Amersham Pharmacia Biotech). Densitometry of p21 and β-tubulin
immunoreactive bands was performed using Open Lab.
For staining explant cultures the primary antibodies used were anti-rabbit
Brn3a polyclonal antibody (1:100 dilution) and anti-goat NeuroD polyclonal
antibody (1:100 dilution) incubated at 4 °C for 24 h. The secondary antibodies
used were donkey anti-rabbit IgG-Cy3 (1:200 dilution) and donkey anti-goat
IgG-Cy2 (1:200 dilution) incubated at 25 °C for 1 h.
For immunohistochemical analysis the embryos were fixed in 4% para-
formaldehyde/PBS and embedded in gelatin. 16 μm sections were cut on a Leica
cryostat and stained with a primary anti-rabbit Brn3a polyclonal antibody (1:100
dilution) incubated at 4 °C for 24 h and a secondary antibody donkey anti-rabbit
IgG-Cy3 (1:200 dilution) incubated at 25 °C for 1 h. In control sections the
primary antibody was omitted.Results
Neural tube explant cultures from lumbar regions of E10.0
Sp/Sp embryos show decreased neural crest cell migration and
premature neurogenesis
‘Splotch’ (Sp/Sp) is an established mouse model for neural
tube defects (NTD), associated with spina bifida and exence-
phaly (Fig. 1A). Epstein et al. (1993) demonstrated that a com-
plex mutation in the Pax3 gene of Sp/Sp embryos resulted in the
generation of 4 aberrantly spliced mRNA transcripts. None of
these transcripts produced functional Pax3 proteins (Epstein
et al., 1993). To examine the functional consequence of non-
functional Pax3 in Sp/Sp embryos, neural tube explant cultures
from the lower lumbar (caudal) region of E10.0 (Figs. 1B and
C) wild-type and Sp/Sp embryos were grown in Neurobasal
medium supplemented with bFGF and EGF onMatrigel. Neural
crest cells from 140 h neural tube explant cultures were allowed
to differentiate in Neurobasal medium without growth factors
for 2 additional days and then stained for NeuroD (neuronal
marker), Brn3a (sensory neurogenesis marker) and DAPI (nuc-
lear stain) (Fig. 1C).
At E10.0 neural crest cells from the caudal neural tube of
Sp/Sp embryos had a 2.5±0.27 (n=5) times lower migration
index than cells from wild-type embryos (Fig. 1B). Neural crest
cells from the caudal neural tube of Sp/Sp embryos also showed
premature differentiation and neurogenesis as evidenced by a
significant increase (pb0.001) in Brn3a (Figs. 1C and D). The
expression of neuronal marker NeuroD was not significantly
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Pax3 produces premature neurogenesis.
To ascertain whether premature neurogenesis persists at a
later time point, we examined the explants cultures of E12.5
embryos. A significant reduction in neural crest cell migration
was observed in both wild type and Sp/Sp embryos (data not
shown). We also observed a significant reduction (pb0.0001;
n=5) in Brn3a staining in Sp/Sp embryos (Figs. 1E and F).
This data suggests that premature neurogenesis does not persist
in Sp/Sp embryos at a later developmental time point, E12.5
probably owing to depletion in neural precursor cells. This is in
agreement with data from Koblar et al. (1999), showing sig-Fig. 1. Neural tube explant cultures from lumbar regions of E10.0 Sp/Sp embryos sh
wild-type (closed neural tube, shown by yellow arrows) and Sp/Sp embryo (open neur
tube explants from the lower lumbar neural tube region of E10.0 wild-type and Sp/Sp
crest cells were allowed to differentiate in the absence of growth factor for 2 days. On
(n=5) fold higher neural crest migration (5× magnifications) than Sp/Sp embryos. (C)
cultures were stained with anti-Brn3a, anti-NeuroD antibodies and DAPI. (D) Brn3
explant cultures were counted and expressed as a percentage of DAPI positive cells. N
neurogenesis, as evidenced by a significant increase in Brn3a (pb0.001 determined b
wild-type and Sp/Sp embryos. (E) Neural tube explants from the lower lumbar neura
differentiation, neural crest cells from wild-type and Sp/Sp embryo explant culture
NeuroD and DAPI positive cells from 5 separate E12.5 Sp/Sp and wild-type explan
Neural crest cells from Sp/Sp embryos did not demonstrate Brn3a positive cells. Neura
comparison to Sp/Sp embryos (pb0.0001 determined by Student's t-test).nificant reduction of Brn3a positive cells in neural tube explants
from late (E12.0) developmental stages of Sp/Sp embryos.
Brn3a and NeuroD staining was also examined in intact E10.0
wild type (closed neural tube) and Sp/Sp (open neural tube)
embryos. Immunohistochemical analysis demonstrated lower
levels of Brn3a positive staining in wild type, as compared with
Sp/Sp, sections. Brn3a positive staining was prominently pre-
sent on the open neural folds of Sp/Sp embryos (Supplemental
Fig. S1). Taken together, our explant and immunohistoche-
mical data from E10.0 embryos suggested that Brn3a staining
was increased in Sp/Sp embryos as compared to wild type
embryos.ow decreased neural crest cell migration and premature neurogenesis. (A) E10.0
al tube with exencephaly and spina bifida, shown by yellow arrows). (B) Neural
embryos were initially grown in the presence of EGF and bFGF. At 140 h neural
examination, the neural tube explants from wild-type embryos showed 2.5±0.27
After differentiation, neural crest cells from wild-type and Sp/Sp embryo explant
a, NeuroD and DAPI positive cells from 5 separate E10.0 wild-type and Sp/Sp
eural crest cells from E10.0 Sp/Sp embryos showed premature differentiation and
y Student's t-test). Expression of NeuroD was not significantly different between
l tube region of E12.5 wild-type and Sp/Sp embryos were grown as above. After
s were stained with anti-Brn3a, anti-NeuroD antibodies and DAPI. (F) Brn3a,
t cultures were counted and expressed as a percentage of DAPI positive cells.
l crest cells from wild-type embryos showed increased Brn3a positive staining in
Fig. 1 (continued).
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Since inactivation of Hes1 accelerates early neurogenesis
(Ishibashi et al., 1994; Tomita et al., 1996; Ohtsuka et al.,1999; Cau et al., 2000; Nakamura et al., 2000; Kageyama et
al., 2005), we surmised that Hes1 expression might be affected
in Pax3 mutant embryos. In order to test this hypothesis, we
performed whole mount in situ hybridization using digox-
Fig. 1 (continued).
515H. Nakazaki et al. / Developmental Biology 316 (2008) 510–523igenin labeled murine Hes1 riboprobes on E10.0 wild type and
Sp/Sp embryos (Fig. 2A). Hes1 staining was reduced in the
migrating neural crest cells in Sp/Sp embryos. These
qualitative observations suggest that Hes1 transcript levelsare reduced in Sp/Sp embryos as compared with wild type
litter-mates.
To establish a quantitative estimation of Hes1 transcripts, we
did real time quantitative RT-PCR of Hes1 from total RNA
516 H. Nakazaki et al. / Developmental Biology 316 (2008) 510–523isolated from the caudal region of wild type, Sp+/− hetero-
zygous and Sp/Sp homozygous embryos at three different
embryonic stages, E9.0, E10.5 and E11.5 (Fig. 2B). At E9.0
Hes1 transcript levels decreased ∼1.5 fold in Sp+/− heterozy-
gous and ∼1 fold in Sp/Sp homozygous embryos as compared
with wild type embryos. At E10.5, Hes1 transcript levels were0.5 to 1 fold lower in Sp+/− embryos and 16 fold lower in
Sp/Sp homozygous embryos as compared with the wild type
embryos. This data shows that Hes1 transcript levels are dec-
reased in Pax3 mutant embryos, suggesting that Pax3 may be
regulating Hes1 during mouse embryonic development.
Mutant Sp/Sp embryos have lower Ngn2 transcript levels at
later stages of embryonic development
Since Ngn2 enhances cell migration and induces neurogen-
esis (Ge et al., 2006; Lo et al., 2002) we surmised that Ngn2
expression might be affected in Pax3 mutant embryos. In order
to test this hypothesis, we performed whole mount in situ hy-
bridization using digoxigenin labeled murine Ngn2 (Fig. 2C)
riboprobes on E10.0 wild type and Sp/Sp embryos. Ngn2
staining was significantly lower in Sp/Sp embryos in the dorsal
neural tube. These qualitative observations suggest that Ngn2
transcript levels are reduced in Sp/Sp embryos as compared
with wild type litter-mates.
To establish a quantitative estimation of Ngn2 transcripts we
did real time quantitative RT-PCR of Ngn2 from total RNA
isolated from the caudal region of wild type, Sp+/− hetero-
zygous and Sp/Sp homozygous embryos at three different deve-
lopmental time points, E9.0, E10.5 and E11.5 (Fig. 2D). Ngn2
expression in Sp+/− embryos as compared to wild type litter-
mates showed a 0.5 fold increase at E9.0, no change at E10.5
and a ∼0.75 fold decrease at E11.5. Ngn2 expression in Sp/Sp
homozygous embryos as compared to wild type littermates
showed no change at E9.0, a 1 fold decrease at E10.5 and a 1.5
to 2 fold decrease at E11.5. This data indicate that in Pax3
mutant embryos, there is a greater effect on Ngn2 transcript
levels at later developmental stages (E11.5). This suggests Pax3
regulates Ngn2 at these later stages.
Functional analysis of Pax3 responsive cis-regulatory elements
in murine Hes1 and Ngn2 promoter
The above observations indicated that Pax3 may be regu-
lating Hes1 and Ngn2 expression in the developing spinal cord.Fig. 2. Whole mount in situ hybridization of wild type and Sp/Sp E10.0 (30
somite) embryos using digoxigenin-labeled murine Hes1 and Ngn2 riboprobes.
(A) Expression of Hes1mRNA in embryonic neural crest cells. Hes1 expression
is significantly reduced in Sp/Sp embryos. Note the reduction of Hes1 positive
staining in migrating neural crest cells in Sp/Sp embryos shown by arrows in the
inset. Staining was not observed with the sense riboprobe (data not shown). (B)
The expression of murine Hes1 was analyzed by RT-PCR using the 7700
Sequence Detection System (Perkin Elmer). The data (n=4; mean±S.E.M)
shows fold induction of Hes1 transcript levels in Sp+/− heterozygous and Sp/Sp
homozygous E9.0, E10.5 and E11.5 embryos as compared to wild type
littermates. (C) Expression of Ngn2 mRNA in embryonic neural crest cells.
Note the dorsal and ventro-lateral Ngn2 staining in wild type embryos and a
reduction of the dorsal Ngn2 staining in Sp/Sp embryos in the inset. Staining
was not observed with the sense riboprobe (data not shown). (D) The expression
of murine Ngn2 was analyzed by RTPCR using the 7700 Sequence Detection
System (Perkin Elmer). The data (n=4; mean±S.E.M.) shows fold induction of
Ngn2 transcript levels in Sp+/− heterozygous and Sp/Sp homozygous E9.0,
E10.5 and E11.5 embryos as compared to wild type litter mates. For B and D the
data was normalized to β-actin levels. Experiments were performed in
quadruplicate with each data point in duplicate.
Fig. 3. Identification of Pax3 response region in murineHes1 promoter. (A) Murine Hes1 promoter region within the −467 to +46 luciferase construct (Takebayashi et
al., 1994) which contained the Pax3 response region. The “cc” within the putative Pax3 homeodomain binding sites ccttg (bp34–38) and ccttg (bp254–258) were
mutated in Hes1 mutant 1 and Hes1 mutant 2 promoter luciferase constructs respectively. (B) Pax3-pcDNA3 or control pcDNA3 constructs were co-transfected with
murine Hes1 promoter-luciferase construct, Hes1mut#1 promoter construct, Hes1mut#2 promoter construct or pGL3 (promoter-less luciferase gene) into wild type
DAOY cells. Luciferase activity was assayed 48 h after transfection. pRLnull (5 ng/well) was used as a transfection control. Experiments were performed in
quadruplicate with each data point in duplicate.
Fig. 4. Identification of Pax3 response region in murine Ngn2 promoter. (A) Minimal essential murine Ngn2 promoter region (1.2 kb) that contains Pax3 binding
elements. The underlined sequence is the putative Pax3 binding homeodomain site on the Ngn2 promoter. (B) Pax3-pcDNA3 or pcDNA3 constructs were co-
transfected with murine Ngn2 promoter-luciferase construct or mutant Ngn2 promoter constructs mut1 (bp5498–5880 deleted), mut2 (bp5498–6334 deleted), mut3
(bp6484–6745 deleted), mut4 (bp6470–7254 deleted), mut5 (bp5498–6754 deleted) and mut5Δgttcc (gttcc; bps7184–7188 deleted from mut5) or pGL3 (promoter-
less luciferase gene) into DAOY cells. Luciferase activity was assayed 48 h after transfection. pRLnull (5 ng/well) was used as a transfection control. Experiments were
performed in quadruplicate with each data point in duplicate.
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region at the 3′ end of the promoter within the −467 to +46
Hes1 promoter construct (Takebayashi et al., 1994), containing
Pax3 responsive cis-regulatory elements (bp34–38) ccttg and
(bp254–258) ccttg (Fig. 3A). Co-transfecting the minimal
essential Hes1 promoter-luciferase construct (as depicted in
Fig. 3A) with Pax3-pcDNA3 caused a significant increase in
promoter activity (Fig. 3B). Mutating “cc” within the Pax3
binding sites (bp34–38) ccttg in Hes1 mutant 1 and (bp254–
258) ccttg in Hes1 mutant 2 (Fig. 3B) completely diminished
Hes1 promoter activity in transient co-transfection experiments.Fig. 5. Identification ofHes1 and Ngn2 as a biological target of Pax3. (A) EMSA of bi
Hes1oligo#1: 5′-cattggccgccagaccttgtgcctagcggc-3′ and Hes1oligo#2: 5′-tgtctacctctc
oligoNgn2: 5′-gacaccgtgctcggttccgggctgcgggga-3′ (the underlined sequence in F
oligonucleotide. The stars represent shifted bands and arrows represent super-shif
represents nuclear extracts from DAOY cells stably transfected with Pax3. (B) EMSA
double-stranded oligonucleotides noted above. The mutant oligonucleotides the “cctt
mutated to gttaa did not bind Pax3 from nuclear extracts or GST-Pax3 in the bindinThese observations suggested that the minimal essential Hes1
promoter contains Pax3 responsive cis regulatory elements.
Similarly, Ngn2 promoter (1.2 kb fragment) (bp5498–7254)
activity increased when co-transfected with Pax3-pcDNA3
expression construct (Fig. 4A). Deleting the 5′ end, in Ngn2
mutant#1 (bp5498–5880 deleted), did not diminish promoter
activity. However, further deletion of the 5′ end in Ngn2mu-
tant#2 (bp5498–6334 deleted), increased promoter activity,
suggesting that the 5′ end of the Ngn2 promoter may contain
elements that repress promoter activity. This hypothesis was
supported with Ngn2mutant#4 (bp6470–7254 deleted), whichnding reactions performed with 32P-labeled double-stranded oligonucleotides—
tccttggtcctggaatag-3′ (the underlined sequences in Fig. 3A); and Ngn2 promoter
ig. 4A) in the absence or presence of 100-fold molar excess of unlabeled
ted bands. D represents nuclear extracts from wild-type DAOY cells and B9
of binding reactions performed using Pax3–GST fusion protein and 32P-labeled
g” in Hes1oligo #1 and Hes1oligo #2 mutated to aattg and “gttcc” in oligoNgn2
g assay (data not shown).
Fig. 6. Pax3 binds to Hes1 and Ngn2 promoter cis-regulatory elements. (A)
ChIP assays using E10.0 (30 somite) lumbar neural tube from wild-type and
open neural tube from Sp/Sp embryos. ChIP compatible antibodies against
Pax3, were used to immunoprecipitate (IP) the protein–DNA complex. IgG was
used as an IP negative control. Murine β-actin primers were used as negative
controls, and the amplified product was present only in the input and not in the
control IgG or the immunoprecipitate. (B) The 200-bp amplified product using
Hes1 and Ngn2 promoter primer sets are shown. Each ChIP experiment was
performed in triplicate using one lumbar neural tube region per chip assay with a
total of n=4.
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activity (Fig. 4B). This implies that the minimal Ngn2 promoter
region responsive to Pax3 was at the 3′-end of the promoter,
defined by Ngn2mutant#5 (bp6755–7254). Ngn2mutant#5
showed increased promoter activity; however deleting ‘gttcc’
(mut5Δgttcc; bps7184–7188) in Ngn2mutant#5 (bp6755–
7254) abolished Ngn2 promoter activities (Fig. 4B). In sum-
mary, Pax3 response elements regulating Ngn2 promoter acti-
vity appear to be located at the 3′ end of the promoter.
Identification of Pax3 binding sequences in murine Hes1 and
Ngn2 promoters
To confirm the above observations and identify Pax3 binding
sequences in murine Hes1 and Ngn2 promoters, we used 30
mer oligonucleotides made from within the region of the Hes1
and Ngn2 promoter which diminished promoter activity upon
mutation. These were Hes1oligo#1 and Hes1oligo#2 that en-
compassed bp34–38 and bp254–258 within Hes1 mutant#1
and mutant#2 constructs respectively (Figs. 5A and B). Oligo-
Ngn2 encompassed the bp7184–7188 deletion within the
Ngn2mutant#5 promoter construct (Figs. 5A and B). Electro-
mobility shift assays (EMSA) using these oligonucleotides and
nuclear extracts from control wild-type DAOY (D) cells and
DAOY cells stably transfected with Pax3 (B9) (Mayanil et al.,
2000, 2006) showed Pax3 binding to these oligonucleotides.
Pax3 binding specificity was confirmed with Pax3 antibody in
super-shift assays (Fig. 5A) and GST-Pax3 binding assays (Fig.
5B). Additionally, the mutant oligonucleotides “ccttg” in Hes1-
oligo #1 and Hes1oligo #2 mutated to aattg and “gttcc” in
oligoNgn2 mutated to gttaa did not bind Pax3 from nuclear
extracts or GST-Pax3 in the binding assay (data not shown).
These data indicated that Pax3 binds to the cis-regulatory
elements in Hes1 and Ngn2 promoters in vitro.
ChIP analysis of Pax3 binding to Hes1 and Ngn2 promoters
In order to address whether normal and mutant Pax3 binds to
the cis-regulatory elements of the Hes1 and Ngn2 promoters in
the intact embryos, we performed chromatin immunoprecipita-
tion (ChIP) experiments using the lower lumbar region of the
neural tube from wild-type and Sp/Sp embryos (both E10.0, 30
somite stage) (Fig. 6A). Using forward and reverse primers
spanning the Hes1 and Ngn2 promoter regions (as described in
Fig. 6B) we observed that Pax3 from wild type embryos bound
Hes1 and Ngn2 promoters whereas mutant Pax3 from Sp/Sp
mutant embryos did not.
Neural precursors from Sp/Sp embryos do not form
neurospheres in culture and over-express p21
Since up-regulated Hes1 is responsible for neural crest stem
cell proliferation and maintenance (Shen et al., 2004), we tried
to expand neural precursor cells obtained from wild-type and
Sp/Sp embryos as neurospheres. Neural crest precursor cells
obtained from wild-type embryos expanded in culture as
neurospheres, whereas those obtained from Sp/Sp neural crestdid not (Fig. 7A), as could be expected with decreased levels of
Hes1, and therefore a decreased stem cell population. In light of
these results we were interested in examining p21 levels in Sp/
Sp embryos. Data from other labs has shown that up-regulating
p21 reduces stem cell populations (Kippin et al., 2005; Hatfield
et al., 2005), and HES-1 represses transcription of the p21cip1
promoter, a cyclin-cyclin-dependent kinase inhibitor (Castella
et al., 2000). In Sp/Sp embryos we expected p21 to be up-
regulated. Immunoblots using p21 antibody with caudal neural
tube extracts from E10.0 wild type and Sp/Sp embryos showed
p21 up-regulated approximately 2 fold in Sp/Sp embryos (Figs.
7B and C). These observations suggest that neural precursors
from Sp/Sp embryos may not expand in culture as neurospheres
because of p21 over-expression.
Discussion
Neurogenesis is a multi-step process that includes precursor
cell proliferation, cell migration, cell differentiation, integration
into neuronal circuits, and survival. All these steps rely on gene
transcription. Our data indicate that Pax3 mutant embryos
Splotch (Sp/Sp) exhibit premature neural crest neurogenesis. We
observed nearly a 6 fold increase in premature sensory neu-
rogenesis in neural tube explant cultures from E10.0 Sp/Sp
embryos compared with age matched wild type embryos, as
evidenced by an increase in the sensory neurogenesis marker
Brn3a. By E12.5 Brn3a positive staining in Sp/Sp embryos was
significantly reduced. This data is in agreement with a report by
Koblar et al. (1999), showing a 5 fold decrease in sensory-like
neurons generated in neural crest cultures from Sp/Sp
Fig. 7. Neural precursors from Sp/Sp embryos do not form neurospheres in culture and over-express p21. (A) Neurospheres from the lumbar regions of E10.0 wild type
and Sp/Sp embryos. Note that even after 10 days in culture, the neural precursors from Sp/Sp embryos did not form neurospheres. (B) Western blot of E10.0 wild type
and Sp/Sp lumbar neural tube extract using p21 antibody. β-tubulin antibody was used to detect β-tubulin as a loading control. (C) Densitometry units (DU) of p21
relative to β-tubulin indicate an increase in p21 protein levels in Sp/Sp embryos.
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It is likely that at later stages a majority of the prematurely
developed neurons have died due to reduced Hes1 expression at
earlier developmental stages. Reduced neural stem cell
proliferation may have depleted the pool of stem/progenitor
cells necessary for proper neurogenesis. In support of this
notion, we observed that the neurospheres prepared from Sp/Sp
embryos showed significantly reduced self-renewing capacity.
Earlier reports have recognized two roles for Pax3 in
precursor cell populations: migration and differentiation (Buck-
ingham and Relaix, 2007; Maschhoff and Baldwin, 2000). Inskeletal muscle development, Pax3 has two functions, myoblast
migration from the dermomyotome to the limb bud (Daston
et al., 1996), and transcriptional activation of myogenesis
(Tajbakhsh et al., 1997; Maroto et al., 1997; Péault et al., 2007).
Pax3 also has roles in neural differentiation pathways as
revealed in several systems. In the Schwann cell lineage, Pax3
mRNA was found to be expressed in two phases; in the later
phase (E18.5 to P5), Pax3 regulated myelin basic protein
expression (Kioussi et al., 1995).
Since Splotch (Sp/Sp) embryos lack functional Pax3 and
exhibit increased sensory neurogenesis, it is possible that Pax3
521H. Nakazaki et al. / Developmental Biology 316 (2008) 510–523may play a role in regulating neurogenesis. Studies by Bel-
Vialar et al. (2007) showed that turning off Pax6, in neural
progenitor precursors was sufficient to provoke premature
differentiation. Sugimori et al. (2007) found that Pax6, along
with other transcription factors, has a key role in controlling the
timing of neurogenesis and gliogenesis in the developing ver-
tebrate spinal cord by way of either enhancing or inhibiting the
activities of the proneural HLH factors Ngn1 (Neurog1), Ngn2
(Neurog2), Ngn3 (Neurog3) and Mash1 (Ascl1), and the inhi-
bitory bHLH factors Id1 and Hes1.
We hypothesized that if Pax3 does play a role in neuro-
genesis it may do so by regulating bHLH factors involved in
this process. In this study we wanted to determine if Pax3 plays
a role in regulating Hes1 and Ngn2, two key bHLH trans-
cription factors responsible for proper maintenance of neural
stem cells and sensory neuron differentiation, respectively.
Hes1 knockout embryos show premature neurogenesis (Ishiba-
shi et al., 1995). We surmised that one potential reason Sp/Sp
embryos exhibit premature neurogenesis could be due to a lack
of proper Hes1 regulation by Pax3. We further surmised that in
addition to regulating Hes1, a repressor type bHLH, Pax3 may
also play a role in regulating a proneural, activator type bHLH,
such as Ngn2 which plays a critical role in sensory neurogenesis
(Lo et al., 2002).
In the present study, we observed that in Sp/Sp embryos
which express non-functional mutant Pax3, Hes1 and Ngn2
transcript levels were reduced in comparison to wild-type
littermates. We also found that Pax3 regulates Hes1 and Ngn2
by binding to cis-regulatory elements on their promoters. These
results suggest that Pax3 may have two roles to play: (i) to
maintain the “stem cell-ness” of migratory neural crest cells by
regulating the repressor type bHLH gene Hes1 during early
stages of development; (ii) to initiate the development of neu-
ronal lineage and to promote the generation of progenitors that
are committed to differentiation by regulating a proneural and
activator type bHLH gene, Ngn2, at later stages of development
when the stem/progenitor cells ceases to proliferate and start to
differentiate into neurons. Our data suggest that of the two
bHLH genes, Hes1 may be the “first hit” gene in the Sp/Sp
embryos and at a later developmental time point Ngn2 may also
get affected. Thus by regulating Hes1, Pax3 may maintain
neural crest cells in an undifferentiated state prior to their mig-
ration to target areas. By regulating Ngn2, Pax3 may ensure that
positional information is integrated into the neurogenesis pro-
cess and to the specification of progenitor-cell identity. Inter-
estingly, in conjunction with data from Bel-Vialar et al. (2007) it
seems quite plausible that the paired domain transcription
factors such as Pax6 and Pax3 affect neurogenesis in spinal cord
in two ways: (i) Pax6 regulating the enhancer for ventral Ngn2
expression in motor neuron precursors within ventral neural
tube (Simmons et al., 2001) and (ii) Pax3 regulating the en-
hancer for dorsal Ngn2 expression in sensory neuron precursors
within dorsal neural tube.
In addition to our main findings we also found that neural
crest precursor cells from Sp/Sp embryos did not expand in
culture as neurospheres with a concomitant up-regulation of p21
in these embryos. Castella et al. (2000) showed that HES-1expression strongly repressed transcription of the p21cip1
promoter, a cyclin–cyclin-dependent kinase inhibitor. Our
results, in combination with those of Castella et al. (2000),
suggest that Pax3 regulates Hes1, which represses p21 promoter
activity and thereby increases progenitor cell proliferation.
In conclusion the data in this study suggest that the paired-
box gene transcription factor, Pax3, may play a crucial role in
neural stem cell maintenance and neurogenesis by regulating
Hes1 and Ngn2. Early in development Pax3 may induce Hes1
activity in conjunction with p21, to ensure that spinal cord pro-
genitors remain in an undifferentiated state prior to migration.
At a later stage Pax3 may up-regulate Ngn2, which is involved
in neural crest cell neurogenesis (Theriault et al., 2005). Fu-
ture studies will be needed to further link Pax3 regulated mi-
gration with neural stem cell maintenance as well as sensory
neurogenesis.
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